Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederinvestor.lilly.com
Eli Lilly and Company News Releases
Get the latest updates from Eli Lilly and Company News Releases directly as they happen.
Follow now 216 followers
Latest posts
Last updated 2 days ago
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin
2 days ago
Efsitora met the primary endpoint in both QWINT-2 and QWINT-4 with once-a-week...
Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer
3 days ago
INDIANAPOLIS , May 15, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE...
Lilly Update on Mounjaro® and Zepbound® (tirzepatide) Compounding Litigation
4 days ago
Following a series of lawsuits Eli Lilly and Company filed in September...
Lilly Statement on FDA Advisory Committee Meeting on Donanemab for Early Symptomatic Alzheimer’s Disease
11 days ago
The U.S. Food and Drug Administration (FDA) will convene an in-person meeting...
Lilly Declares Second-Quarter 2024 Dividend
12 days ago
INDIANAPOLIS , May 6, 2024 /PRNewswire/ -- The board of directors of...
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
18 days ago
Revenue in Q1 2024 increased 26%, driven by Mounjaro, Zepbound, Verzenio and...
Lilly Recommends Shareholders Reject “Mini-Tender” Offer by Tutanota LLC
22 days ago
INDIANAPOLIS, April 26, 2024 – Eli Lilly and Company (NYSE: LLY) has...
Lilly Acquires New Injectable Medicine Manufacturing Facility from Nexus Pharmaceuticals
26 days ago
Upon completion, this acquisition will expand Lilly's growing U.S. capacity to produce...
Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity
about 1 month ago
Tirzepatide achieved a mean apnea-hypopnea index reduction of up to 63% (about...
Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement
about 1 month ago
INDIANAPOLIS , April 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE...
Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® (empagliflozin) on risk of heart failure hospitalization and death in adults following a heart attack
about 1 month ago
RIDGEFIELD, Conn. and INDIANAPOLIS, April 6, 2024 – The EMPACT-MI phase III...
More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab study
2 months ago
INDIANAPOLIS , March 10, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE...